NCT07435740

Brief Summary

This study will evaluate the efficacy of a structured parent-mediated behavioral intervention called Sleep Parent Treatment (SPT) for insomnia in autistic children ages 3 to 7 years 11 months, compared to another behavioral intervention called Sleep Parent Education (SPE). Eligible children will be randomly assigned to either the SPT or SPE intervention for 10 weeks.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
130

participants targeted

Target at P50-P75 for not_applicable

Timeline
56mo left

Started Jun 2026

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress1%
Jun 2026Jan 2031

First Submitted

Initial submission to the registry

February 20, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 27, 2026

Completed
3 months until next milestone

Study Start

First participant enrolled

June 1, 2026

Completed
4.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2031

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2031

Last Updated

May 14, 2026

Status Verified

May 1, 2026

Enrollment Period

4.6 years

First QC Date

February 20, 2026

Last Update Submit

May 12, 2026

Conditions

Keywords

autism

Outcome Measures

Primary Outcomes (1)

  • Pediatric Autism Insomnia Scale (PAIRS) Score

    Insomnia severity is assessed with the Pediatric Autism Insomnia Scale (PAIRS) instrument. The PAIRS is a 21- item measure designed to capture the frequency and impact of insomnia (e.g., trouble initiating or maintaining sleep) in autistic children. Responses to items are scored on a 4-point scale, ranging from 0 to 3. Example of items are "My child has a bedtime routine; small changes throw it off" and "My child has a hard time settling down to fall asleep at night." Total scores range from 0 to 63, with higher score reflecting greater severity of insomnia symptoms. A score of \>30 is required for study entry.

    Baseline, Week 5, Week 10

Secondary Outcomes (1)

  • Rate of Positive Response on the Clinical Global Impression - Improvement (CGI-I) Scale

    Week 10

Study Arms (2)

Sleep Parent Treatment (SPT)

EXPERIMENTAL

Autistic children with moderate or greater insomnia who are randomly assigned to receive 5 sessions of Sleep Parent Treatment (SPT) delivered over 10 weeks.

Behavioral: Sleep Parent Training (SPT)

Sleep Parent Education (SPE)

ACTIVE COMPARATOR

Autistic children with moderate or greater insomnia who are randomly assigned to receive 5 sessions of Sleep Parent Education (SPE) delivered over 10 weeks.

Behavioral: Sleep Parent Education (SPE)

Interventions

Five SPT sessions, each 60-90 minutes in duration, are individually delivered over 10 weeks. Each session employs direct instruction, modeling, and role-playing to promote parental skill acquisition. The SPT manual includes a therapist script and parent activity sheets for each session. Video vignettes for each session model specific techniques, including correct application of a technique and ineffective strategies. To supplement the 5 sessions, three virtual parent-child coaching sessions occur to ensure implementation fidelity. A sleep plan for the child is developed with the parent and is revised, as needed, at each session.

Sleep Parent Treatment (SPT)

SPE includes five 60-90 minute sessions, delivered individually over 10 weeks. SPE provides useful information to families of young children with ASD and insomnia. The sessions cover a review of autism, sleep hygiene, interpretation of clinical evaluations, child advocacy and evaluation of available treatments, and information on evidence-based treatments.

Sleep Parent Education (SPE)

Eligibility Criteria

Age3 Years - 7 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age \>3 to 7 years 11 months
  • Clinical diagnosis of ASD supported by the Autism Diagnostic Interview Revised (ADI-R)
  • Score of 30 or more on the Parent-Rated Insomnia Scale - ASD (PAIRS) and the Clinical Global Impression Severity (CGI-S) score of Moderate or greater (a score of 4 or more)
  • Medication and supplement free or on stable medication or supplements (no changes in the past 6 weeks and no planned changes for 10 weeks of the randomized trial)
  • Parental proficiency in spoken and written English language. Study materials and many of the study measures are only available in English

You may not qualify if:

  • Children with a history of serious medical condition or known medical cause insomnia (e.g., nocturnal seizures, unresolved gastrointestinal problems such as reflux or constipation)
  • Children with a psychiatric disorder or serious behavioral problem requiring a different treatment
  • Children with known sleep apnea, restless leg syndrome, or periodic limb movements during sleep, or a circadian-based sleep disorder (e.g., delayed or advanced sleep phase syndrome)
  • Children of non-English language speaking caregivers will be excluded because study intervention materials and many of the study measures are only available in English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Emory School Of Medicine

Atlanta, Georgia, 30322, United States

Location

Case Western Reserve University

Cleveland, Ohio, 44106, United States

Location

Ohio State University

Columbus, Ohio, 43210, United States

Location

MeSH Terms

Conditions

Sleep Initiation and Maintenance DisordersAutistic Disorder

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental DisordersAutism Spectrum DisorderChild Development Disorders, PervasiveNeurodevelopmental Disorders

Study Officials

  • Luc Lecavalier, PhD

    Ohio State University

    PRINCIPAL INVESTIGATOR
  • Cynthia R Johnson

    Cleveland Clinic Center for Autism

    PRINCIPAL INVESTIGATOR
  • Lawrence Scahill, MSN, PhD

    Emory University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Cynthia Johnson, PhD

CONTACT

Luc Lecavalier, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

February 20, 2026

First Posted

February 27, 2026

Study Start

June 1, 2026

Primary Completion (Estimated)

January 1, 2031

Study Completion (Estimated)

January 1, 2031

Last Updated

May 14, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations